Ruethrich, Maria Madeleine, Giesen, Nicola, Mellinghoff, Sibylle C., Rieger, Christina T. and von Lilienfeld-Toal, Marie (2022). Cellular Immune Response after Vaccination in Patients with Cancer-Review on Past and Present Experiences. Vaccines, 10 (2). BASEL: MDPI. ISSN 2076-393X

Full text not available from this repository.

Abstract

Patients with cancer are at particular risk for infection but also have diminished vaccine responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are specifically recommended in this vulnerable patient group. Here, we discuss the cellular part of the vaccine response in patients with cancer. We summarize the experience with vaccines prior to and during the SARS-CoV-2 pandemic in different subgroups, and we discuss why, especially in patients with cancer, T cells may be the more reliable correlate of protection. Finally, we provide a brief outlook on options to improve the cellular response to vaccines.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Ruethrich, Maria MadeleineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Giesen, NicolaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mellinghoff, Sibylle C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rieger, Christina T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Lilienfeld-Toal, MarieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-682210
DOI: 10.3390/vaccines10020182
Journal or Publication Title: Vaccines
Volume: 10
Number: 2
Date: 2022
Publisher: MDPI
Place of Publication: BASEL
ISSN: 2076-393X
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CD4(+) T-CELLS; INFLUENZA VACCINATION; ANTIBODY-RESPONSES; ZOSTER VACCINE; B-CELL; HEMATOLOGIC MALIGNANCIES; TRANSPLANT RECIPIENTS; COVID-19 VACCINATION; INFECTIOUS-DISEASES; CYTOKINE PRODUCTIONMultiple languages
Immunology; Medicine, Research & ExperimentalMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/68221

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item